Aptevo Therapeutics Cash from Financing (TTM) Insights

Aptevo Therapeutics Inc (APVO)

0.7608 +0.05 (+6.78%) USD | NASDAQ | Apr 18, 15:56

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	5.998M
September 30, 2023	8.95M
June 30, 2023	4.106M
March 31, 2023	0.447M
December 31, 2022	-2.616M
September 30, 2022	-11.69M
June 30, 2022	-14.21M
March 31, 2022	-2.717M
December 31, 2021	26.16M
September 30, 2021	50.48M
June 30, 2021	78.24M
March 31, 2021	69.92M
December 31, 2020	23.87M
September 30, 2020	2.491M
June 30, 2020	-22.22M
March 31, 2020	-22.33M
December 31, 2019	20.15M

Date	Value
September 30, 2019	20.32M
June 30, 2019	19.72M
March 31, 2019	20.14M
December 31, 2018	-0.787M
September 30, 2018	-0.299M
June 30, 2018	0.102M
March 31, 2018	-0.217M
December 31, 2017	19.53M
September 30, 2017	20.11M
June 30, 2017	75.58M
March 31, 2017	94.87M
December 31, 2016	89.30M
September 30, 2016	97.55M
June 30, 2016	51.48M
March 31, 2016	50.57M
December 31, 2015	51.33M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-22.33M

Minimum

Mar 2020

78.24M

Maximum

Jun 2021

13.43M

Average

5.998M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks